Novo Nordisk posts robust Q2 performance with double-digit profit growth
The Danish pharmaceutical company Novo Nordisk posted a strong Q2, achieving €10.5 bn in sales and €4.465 bn in adjusted operating profit, up 2% and 8% from the previous year.
